ATE326220T1 - Verabreichungsverfahren von s-adenosylmethionin in form eines mikrofeinen pulvers durch inhalieren - Google Patents
Verabreichungsverfahren von s-adenosylmethionin in form eines mikrofeinen pulvers durch inhalierenInfo
- Publication number
- ATE326220T1 ATE326220T1 AT01125055T AT01125055T ATE326220T1 AT E326220 T1 ATE326220 T1 AT E326220T1 AT 01125055 T AT01125055 T AT 01125055T AT 01125055 T AT01125055 T AT 01125055T AT E326220 T1 ATE326220 T1 AT E326220T1
- Authority
- AT
- Austria
- Prior art keywords
- same
- compound
- adenosylmethionine
- inhalation
- administration
- Prior art date
Links
- MEFKEPWMEQBLKI-AIRLBKTGSA-N S-adenosyl-L-methioninate Chemical compound O[C@@H]1[C@H](O)[C@@H](C[S+](CC[C@H](N)C([O-])=O)C)O[C@H]1N1C2=NC=NC(N)=C2N=C1 MEFKEPWMEQBLKI-AIRLBKTGSA-N 0.000 title abstract 4
- 229960001570 ademetionine Drugs 0.000 title abstract 2
- 238000000034 method Methods 0.000 title abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 239000000443 aerosol Substances 0.000 abstract 1
- 238000002716 delivery method Methods 0.000 abstract 1
- 229940112141 dry powder inhaler Drugs 0.000 abstract 1
- 239000007789 gas Substances 0.000 abstract 1
- 239000008101 lactose Substances 0.000 abstract 1
- 239000007788 liquid Substances 0.000 abstract 1
- 239000012528 membrane Substances 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 239000003961 penetration enhancing agent Substances 0.000 abstract 1
- 239000003380 propellant Substances 0.000 abstract 1
- 230000000069 prophylactic effect Effects 0.000 abstract 1
- 210000002345 respiratory system Anatomy 0.000 abstract 1
- 239000007921 spray Substances 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
- 230000008016 vaporization Effects 0.000 abstract 1
- 238000009834 vaporization Methods 0.000 abstract 1
- -1 vapors Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
- A61K47/55—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound the modifying agent being also a pharmacologically or therapeutically active agent, i.e. the entire conjugate being a codrug, i.e. a dimer, oligomer or polymer of pharmacologically or therapeutically active compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Otolaryngology (AREA)
- Pulmonology (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT2001PI000015A ITPI20010015A1 (it) | 2001-03-05 | 2001-03-05 | Metodo per la somministrazione di s-adenosil-metionina,sottoforma di micropolvere secca,tramite inalazione |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE326220T1 true ATE326220T1 (de) | 2006-06-15 |
Family
ID=11452986
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT01125055T ATE326220T1 (de) | 2001-03-05 | 2001-10-22 | Verabreichungsverfahren von s-adenosylmethionin in form eines mikrofeinen pulvers durch inhalieren |
Country Status (4)
| Country | Link |
|---|---|
| EP (1) | EP1238665B1 (de) |
| AT (1) | ATE326220T1 (de) |
| DE (1) | DE60119687D1 (de) |
| IT (1) | ITPI20010015A1 (de) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ITMI20130426A1 (it) * | 2013-03-20 | 2014-09-21 | Gnosis Spa | S-adenosilmetionina sterile ad alto contenuto di isomero attivo per soluzioni iniettabili e procedimento per ottenerla |
| GB2525626A (en) * | 2014-04-29 | 2015-11-04 | Alexander Francois Robert Templet | Composition and method for inhalable nutritional element |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT8219012A0 (it) * | 1982-01-06 | 1982-01-06 | Ausonia Farma Srl | Metodo per la somministrazione orale di sostanze sotto forma di liposomi, e relative formulazioni farmaceutiche. |
| JPS59175433A (ja) * | 1983-03-24 | 1984-10-04 | Kanegafuchi Chem Ind Co Ltd | Ｓ−アデノシル−ｌ−メチオニン含有組成物 |
| US5669378A (en) | 1995-12-21 | 1997-09-23 | Pera; Ivo | Inhaling device |
| US5944012A (en) | 1996-03-25 | 1999-08-31 | Pera; Ivo E. | Method for dispensing antioxidant vitamins by inhalation background of the invention |
| DE19631085A1 (de) * | 1996-08-01 | 1998-02-05 | Basf Ag | Verwendung von (Meth)acrylsäure-Maleinsäure-Copolymeren zur Verbesserung der Permeabilität der Schleimhaut |
-
2001
- 2001-03-05 IT IT2001PI000015A patent/ITPI20010015A1/it unknown
- 2001-10-22 EP EP01125055A patent/EP1238665B1/de not_active Expired - Lifetime
- 2001-10-22 DE DE60119687T patent/DE60119687D1/de not_active Expired - Lifetime
- 2001-10-22 AT AT01125055T patent/ATE326220T1/de not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| EP1238665B1 (de) | 2006-05-17 |
| DE60119687D1 (de) | 2006-06-22 |
| EP1238665A1 (de) | 2002-09-11 |
| ITPI20010015A1 (it) | 2002-09-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2225750C (en) | Inhalation device and method | |
| TR200002692T2 (tr) | Aerosol haline getirilen aktif maddenin verilmesi. | |
| EA200100338A1 (ru) | Способ и устройство для введения действующего вещества в виде аэрозоли в легкие пациента | |
| CA2425489A1 (en) | Therapeutic use of aerosolized s-nitrosoglutathione in cystic fibrosis | |
| EP2272508A3 (de) | Pharmazeutische Formulierungen für Pulverinhalatoren | |
| CA2352483A1 (en) | Pharmaceutical aerosol composition containing hfa 227 and hfa 134a | |
| BR0012013A (pt) | Métodos de aerossolizar uma formulação farmacêutica, e de administrar uma formulação farmacêutica, dispositivo de aerossolização, sistema de aerossolização, e, receptáculo | |
| CA2411047A1 (en) | Stable pharmaceutical solution formulations for pressurised metered dose inhalers | |
| IS1768B (is) | Lyfjablanda til innöndunar sem inniheldur insúlín | |
| DE60135099D1 (de) | Pulverinhalator | |
| ATE326220T1 (de) | Verabreichungsverfahren von s-adenosylmethionin in form eines mikrofeinen pulvers durch inhalieren | |
| Crompton et al. | Session Chairmen's Summary | |
| FI77784B (fi) | Inhaleringsanordning. | |
| TH59260A3 (th) | การให้สารออกฤทธิ์ที่ได้รับการทำเป็นแอโรซอล | |
| Bauer et al. | Special Applications of Aerosol Therapy | |
| MXPA98000223A (en) | Device and method of inhalac |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |